https://www.europeanpharmaceuticalreview.com/news/181065/novel-delivery-approach-demonstrates-efficacy-of-immunotherapy/
A novel approach for delivering intrathecal and intravenous immunotherapy improved survival of patients with leptomeningeal disease (LMD).
Create an account or login to join the discussion